Labrucherie Gil M Insider Trades

Insider Trading History

Track insider trading activity for Labrucherie Gil M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Septerna
Septerna SEPN
Chief Financial Officer
Holding Value $3.82M 125,000 shares
Last Trade
Feb 06, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.18M 125,000 shares
$25.41
$30.55
Rezolute
Rezolute RZLT
Director
Holding Value $254k 55,500 shares
Last Trade
Nov 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$335k 33,000 shares
$10.16
$4.58
Septerna
Septerna SEPN
Chief Financial Officer
Holding Value $1.15M 37,500 shares
Last Trade
Aug 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$439k 37,500 shares
$11.70
$30.55
Rezolute
Rezolute RZLT
Director
Holding Value $158k 34,500 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22k 5,000 shares
$4.39
$4.58
Rezolute
Rezolute RZLT
Director
Holding Value $117k 25,500 shares
Last Trade
Feb 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$69.2k 15,000 shares
$4.61
$4.58
Acelyrin
Acelyrin SLRN
CFO And CBO
Holding Value $341k 150,000 shares
Last Trade
Aug 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$717k 150,000 shares
$4.78
$2.27
Rezolute
Rezolute RZLT
Director
Holding Value $137k 30,000 shares
Last Trade
Jan 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30.6k 30,000 shares
$1.02
$4.58
Acelyrin
Acelyrin SLRN
Chief Financial Officer
Holding Value $1.94M 855,513 shares
Last Trade
Jan 09, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.57M 855,513 shares
$7.68
$2.27
Acelyrin
Acelyrin SLRN
Chief Financial Officer
Holding Value $92.5k 40,763 shares
Last Trade
Oct 04, 2023 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$386k 40,763 shares
$9.47
$2.27
Acelyrin
Acelyrin SLRN
Chief Financial Officer
Holding Value $579k 254,939 shares
Last Trade
Aug 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.87M 254,939 shares
$26.94
$2.27
Rezolute
Rezolute RZLT
Director
Holding Value $366k 80,000 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$272k 80,000 shares
$3.40
$4.58
Nektar Therapeutics
Nektar Therapeutics NKTR
Svp, COO & CFO
Holding Value $18.5M 312,905 shares
Last Trade
May 15, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$68.9k 17,448 shares
$3.95
$59.23
Nektar Therapeutics
Nektar Therapeutics NKTR
Svp, COO & CFO
Holding Value $19.6M 330,353 shares
Last Trade
May 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$115k 28,750 shares
$3.99
$59.23
Rezolute
Rezolute RZLT
Director
Holding Value $241k 52,631 shares
Last Trade
May 04, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$200k 52,631 shares
$3.80
$4.58
Rezolute
Rezolute RZLT
Director
Holding Value $245k 53,572 shares
Last Trade
May 04, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$200k 52,631 shares
$3.80
$4.58
Nektar Therapeutics
Nektar Therapeutics NKTR
Svp, COO & CFO
Holding Value $17.9M 301,603 shares
Last Trade
Feb 16, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$83k 7,579 shares
$10.95
$59.23
Nektar Therapeutics
Nektar Therapeutics NKTR
Svp, COO & CFO
Holding Value $18.3M 309,182 shares
Last Trade
Dec 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.24M 94,000 shares
$13.22
$59.23
Nektar Therapeutics
Nektar Therapeutics NKTR
Svp, COO & CFO
Holding Value $15.2M 256,682 shares
Last Trade
Nov 18, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$38.1k 3,000 shares
$12.69
$59.23
Nektar Therapeutics
Nektar Therapeutics NKTR
Svp, COO & CFO
Holding Value $15.4M 259,682 shares
Last Trade
Nov 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$278k 21,149 shares
$13.16
$59.23
Nektar Therapeutics
Nektar Therapeutics NKTR
Svp, COO & CFO
Holding Value $16.6M 280,831 shares
Last Trade
Nov 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$536k 40,150 shares
$13.34
$59.23

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up